Tumor infiltrating ILC2s which express the programmed cell death protein (PD-1) receptor were enriched in long-term survivors with an immunologically hot tumor microenvironment containing abundant activated CD8+ T-cells, and containing higher bulk tumor RNA expression of the ILC2-activating cytokine IL33 (Moral et al., 2020). This evidence concerns the gene CD8A and neoplasm.